268 related articles for article (PubMed ID: 21153816)
1. Intraoperative parathyroid hormone monitoring in patients with recognized multiglandular primary hyperparathyroidism.
Hughes DT; Miller BS; Doherty GM; Gauger PG
World J Surg; 2011 Feb; 35(2):336-41. PubMed ID: 21153816
[TBL] [Abstract][Full Text] [Related]
2. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.
Nilubol N; Weisbrod AB; Weinstein LS; Simonds WF; Jensen RT; Phan GQ; Hughes MS; Libutti SK; Marx S; Kebebew E
World J Surg; 2013 Aug; 37(8):1966-72. PubMed ID: 23722465
[TBL] [Abstract][Full Text] [Related]
3. Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.
Cayo AK; Sippel RS; Schaefer S; Chen H
Ann Surg Oncol; 2009 Dec; 16(12):3450-4. PubMed ID: 19760044
[TBL] [Abstract][Full Text] [Related]
4. Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism.
Shawky M; Abdel Aziz T; Morley S; Beale T; Bomanji J; Soromani C; Lam F; Philips I; Matias M; Honour J; Smart J; Kurzawinski TR
Clin Endocrinol (Oxf); 2019 Feb; 90(2):277-284. PubMed ID: 30346646
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.
Dobrinja C; Santandrea G; Giacca M; Stenner E; Ruscio M; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S26-S33. PubMed ID: 28506410
[TBL] [Abstract][Full Text] [Related]
6. Impact of intraoperative parathyroid hormone monitoring on the prediction of multiglandular parathyroid disease.
Clerici T; Brandle M; Lange J; Doherty GM; Gauger PG
World J Surg; 2004 Feb; 28(2):187-92. PubMed ID: 14708048
[TBL] [Abstract][Full Text] [Related]
7. Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism.
Shawky MS; Sakr MF; Nabawi AS; Abdel-Aziz TE; De Jong MC; García VR; Lam F; Soromani C; Smart J; Honour JW; Kurzawinski TR
J Endocrinol Invest; 2020 Sep; 43(9):1205-1212. PubMed ID: 32124267
[TBL] [Abstract][Full Text] [Related]
8. Significance of rebounding parathyroid hormone levels during parathyroidectomy.
Schneider DF; Ojomo KA; Mazeh H; Oltmann SC; Sippel RS; Chen H
J Surg Res; 2013 Sep; 184(1):265-8. PubMed ID: 23669749
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.
Trinh G; Rettig E; Noureldine SI; Russell JO; Agrawal N; Mathur A; Prescott JD; Zeiger MA; Tufano RP
Otolaryngol Head Neck Surg; 2018 Oct; 159(4):630-637. PubMed ID: 30105919
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive surgery for primary hyperparathyroidism with or without intraoperative parathyroid hormone monitoring.
Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Ito K
Endocr J; 2010; 57(11):953-8. PubMed ID: 20823623
[TBL] [Abstract][Full Text] [Related]
11. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
Heller KS; Blumberg SN
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
[TBL] [Abstract][Full Text] [Related]
12. Minimal benefit to subsequent intraoperative parathyroid hormone testing after all four glands have been identified.
Ahmed K; Alhefdhi A; Schneider DF; Ojomo KA; Sippel RS; Chen H; Mazeh H
Ann Surg Oncol; 2013 Dec; 20(13):4200-4. PubMed ID: 23943032
[TBL] [Abstract][Full Text] [Related]
13. The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis.
Morris LF; Zanocco K; Ituarte PH; Ro K; Duh QY; Sturgeon C; Yeh MW
Ann Surg Oncol; 2010 Mar; 17(3):679-85. PubMed ID: 19885701
[TBL] [Abstract][Full Text] [Related]
14. The role of intraoperative parathyroid hormone (IOPTH) determination for identification and surgical strategy of sporadic multiglandular disease in primary hyperparathyroidism (pHPT).
Bhangu JS; Riss P
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101310. PubMed ID: 31409538
[TBL] [Abstract][Full Text] [Related]
15. The final intraoperative parathyroid hormone level: how low should it go?
Wharry LI; Yip L; Armstrong MJ; Virji MA; Stang MT; Carty SE; McCoy KL
World J Surg; 2014 Mar; 38(3):558-63. PubMed ID: 24253106
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative parathyroid hormone levels ≤40 pg/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism.
Claflin J; Dhir A; Espinosa NM; Antunez AG; Cohen MS; Gauger PG; Miller BS; Hughes DT
Surgery; 2019 Jul; 166(1):50-54. PubMed ID: 30975497
[TBL] [Abstract][Full Text] [Related]
17. What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?
Wachtel H; Cerullo I; Bartlett EK; Kelz RR; Karakousis GC; Fraker DL
Ann Surg Oncol; 2015; 22(6):1781-8. PubMed ID: 25354574
[TBL] [Abstract][Full Text] [Related]
18. RECEIVER OPERATING CHARACTERISTIC ANALYSIS OF INTRAOPERATIVE PARATHYROID HORMONE MONITORING TO DETERMINE OPTIMUM SENSITIVITY AND SPECIFICITY: ANALYSIS OF 896 CASES.
Foley CS; Moore EC; Milas M; Berber E; Shin J; Siperstein AE
Endocr Pract; 2019 Nov; 25(11):1117-1126. PubMed ID: 31414903
[No Abstract] [Full Text] [Related]
19. Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making.
Carr AA; Yen TW; Wilson SD; Evans DB; Wang TS
J Surg Res; 2017 Mar; 209():162-167. PubMed ID: 28032553
[TBL] [Abstract][Full Text] [Related]
20. Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: a two-institution analysis of more than 2,000 patients.
Rajaei MH; Oltmann SC; Adkisson CD; Elfenbein DM; Chen H; Carty SE; McCoy KL
Surgery; 2014 Oct; 156(4):760-6. PubMed ID: 25239313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
